Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-07, Stock:LLY, The news for the past five days is as follows:
2021-05-28: NEWS1: The FDA authorized the third antibody infusion therapy. Here’s why Vir and GSK say the U.S. still needs COVID-19 treatments.NEWS2: U.S. stops distributing Lilly's COVID-19 antibody therapy in six states, instead recommends Regeneron's treatment.NEWS3: Eli Lilly Receives DOJ Subpoena Related to Manufacturing Site.
2021-06-01: NEWS1: OLUMIANT® Improved Pain, Physical Function and Morning Joint Stiffness in Rheumatoid Arthritis in Phase 3 Post-Hoc Analyses.NEWS2: Taltz® Showed Consistent, Long-Term Improvement in Key Signs and Symptoms of Axial Spondyloarthritis Through Two Years in Phase 3 Study.
2021-06-02: NEWS1: Lilly's Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial.NEWS2: Thirty Madison Vaults to Unicorn Status, Raises $140 Million.NEWS3: 15 Most Valuable Pharmaceutical Companies In The World.
2021-06-03: NEWS1: Lilly to Participate in Goldman Sachs Healthcare Conference.NEWS2: Lilly Reveals Critical Barriers to Optimal Migraine Care and Insights From Novel Clinical and Patient-Centric Real-World Evidence, Supporting Lilly's Preventive and Acute Treatment Portfolio at AHS 2021.
2021-06-04: NEWS1: Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know.NEWS2: Merus Reveals New Data From Zeno Program in NRG1 Fusion Cancers.NEWS3: Lilly Announces New Clinical Data from Verzenio and Oral SERD Programs at the American Society of Clinical Oncology Annual Meeting.

Answer: Rise